ABSTRACT The management of heart failure patients via the implantation of cardiac pacemakers has become a well-known therapy. However, the complications associated with traditional cardiac pacemakers are usually related to finite-battery life, transvenous pacing leads, and subcutaneous device pocket. In this paper, we propose a wearable RF-powered leadless pacing system, which can be implanted directly inside the heart and powered via RF energy, without any batteries or pacing leads. More specifically, we have realized a prototype rectenna-based leadless pacemaker (LP), the implant, which consists of an implantable rectenna, charging and pacing circuits, as well as the pacing electrodes. In addition, a wearable transmit-antenna array was designed, developed, and fabricated for RF energy transmission into the body. In an acute animal study, using ovine models, the proposed LP was implanted at the left ventricular apex by thoracotomy. Using the prototype wearable transmit-antenna array, the prototype LP was powered wirelessly and as a result, leadless pacing was successfully demonstrated in the in vivo ECG results. Besides measuring the efficiency of the rectenna, the computations of specific absorption rate (SAR) are presented and found to be under the IEEE recommended limits. We conclude that a wearable RF-powered leadless pacing system is realizable with the SAR under the safe levels. Thus, the proposed leadless pacing method has the potential to be significantly safer as it completely eliminates the battery, leads, and device pocket and all the associated complications.
I. INTRODUCTION
The development of the first fully implantable pacemaker, in 1958 by Senning, was a great success in the history of cardiac resynchronization therapy devices [1] . Since then, the pacemaker industry has been continuously evolving, owing its success to the tremendous advancements in electronics and semiconductors, making pacemakers compactyet smarter and efficient. Despite all the developments, conventional pacemakers are facing longevity issues, mainly due to their finite battery life and infection risks caused by the device pocket and leads, which goes through the circulatory system [2] , [3] . The pacing leads are considered to be the most important part of the cardiac pacing system as they deliver the pulses from the pulse generator (usually implanted in a subcutaneous pocket in the chest) to the heart [4] . Directly connected to the heart, these leads bend approximately 10 6 times per day and hence may suffer from conductor fracture, insulation breaks, and even infection and produce venous obstruction [5] - [8] . In an effort to seek alternative energy sources and eliminate the pacing leads, Eisenberg et al. proposed the first inductively coupled pacemaker in 1961 [9] . Later, Cammilli et al. implanted a receiver coil in the heart and exploited RF impulses for the transmission of stimulations from an externally deployed pacemaker to the heart [10] . The first ever leadless endocardial pacing was demonstrated on humans using ultrasound a few years ago [11] . Moreover, two recently developed single chamber battery-powered leadless pacemakers are Nanostim and Micra TPS (Transcatheter Pacing System), developed by St. Jude Medical (now Abbott) [12] and Medtronic [13] , respectively. Although Nanostim is the first to be studied in patients, it is Micra TPS which earned the approval of FDA (Food and Drug Administration) first. Moreover, Nanostim has been experiencing some issues: (a) lost of telemetry and pacing output due to the malfunction of battery; (b) docking button detachment; Abbott, therefore, has halted the worldwide implants of Nanostim and is currently investigating these issues [14] .
To achieve wireless power transfer for medical implants, common methods include inductive, near-field, mid-field, far-field and magnetic resonance [9] , [15] , [18] - [20] . Very recently, an inductively powered wireless pacemaker with a remote stimulation control system has been proposed [15] . However, the non-planar coil antennas designed for the receiver and transmitter were not practically viable. Also, only ex vivo and post-euthanasia ECG results were reported, and its not tested in a live animal. In [17] , Sun et al. proposed a mm-sized wirelessly powered pacemaker but this method used a horn antenna held 2 cm away from the device, which was also not directly implanted on the heart but connected via apicardial leads. In our previously proposed leadless pacing system [21] , [22] , we implanted the prototype pacemaker on the heart of the ovine model and no leads were used; however, the RF power was transmitted using a horn antenna, which was not practically realizable to perform a sub-chronic study. Additionally, only power density computations were considered and specific absorption rate (SAR) was not addressed.
In this paper, we present a fully wearable RF-powered leadless pacing system and demonstrate its working in an ovine model. The proposed leadless system has two parts: the rectenna-based leadless pacemaker (implant) and wearable transmit-antenna array. First, a rectenna comprising of the receiving antenna, voltage multiplier, and charging circuits was developed. Then, a wearable transmit-antenna array was designed and manufactured for transmitting the RF energy. The extensive simulation procedures of the rectenna and wearable transmitter antenna array were performed in Advanced Design Software (ADS) v. 15.1 [23] and 3D Electromagnetic (EM) software High Frequency Structure Simulator (HFSS) v. 17.2 [24] before the fabrication and manufacturing phase. Finally, an ovine model was used to perform in vivo measurements of the developed setup. The real-time Electrocardiogram (ECG) results of the ovine model showed that the developed system is able to achieve wireless pacing. Furthermore, SAR calculations revealed that our pacing system has values within the recommended the IEEE limits.
II. SYSTEM DESIGN
The overview of the proposed wearable RF-powered leadless pacing system is illustrated in Figure 1 , which shows the FIGURE 1. Overview of the proposed RF-powered leadless pacing system showing anterior (left side) and lateral views (right side) of a human model. The RF power sent via the wearable transmit-antenna is harvested by the implanted electrode in the heart and used to power the pacemaker to provide pacing. anterior and lateral views of the system. As observed from the Figure 1 , there are two main units of this system: the wearable transmit-antenna array and the implant. The wearable transmit-antenna array is connected to the external RF power generator and is body worn while the rectenna-based leadless pacemaker (RLP) is fully implanted in the heart. A flow diagram of the design procedure and methodology is depicted in Figure 2 .
III. DESIGN AND DEVELOPMENT OF A PROTOTYPE RECTENNA-BASED LEADLESS PACEMAKER (RLP)
To realize a complete RLP, various separate modules were designed, developed, manufactured, and tested separately before their final integration into one single module. The main modules or parts of the RLP are:
(a) implantable antenna, (b) rectifier circuit, (c) matching circuit, (d) charging system, and (e) pacing circuit. Details of these modules are described in this section.
A. IMPLANTABLE ANTENNA DESIGN, PROTOTYPE, AND RESULTS
While a plethora of work is available on the implantable antenna [26] - [32] , research on deeply implantable antennas proposed for wireless pacemakers is limited. Designing implantable antennas is challenging due to the strong effects of multi-path losses because of lossy nature of human tissues, reduced antenna efficiency, and miniaturized nature of the antenna. Several types of antennas such as loop antennas [33] , monopole antennas [34] , patch antennas [21] , planar inverted-F antenna (PIFA) [34] , and circumferential antennas [35] have been previously explored for wireless pacemakers. Nonetheless, the efficiency of the reported antennas have been verified individually in simulations and simulating liquids rather than their demonstration in the in vivo models. On the contrary, a planar antenna with Composite Split Ring Resonators (CSSR) is designed at 1.2 GHz in [21] , but the performance of the antenna was verified in vivo experimentation using horn antennas as a transmitter, which makes the design impractical for cardiac pacing applications. Similarly, coil antenna having 40 mm diameter has been demonstrated in the in vivo experimentation [15] ; however, relatively larger size restricts its practical employability for the leadless pacemaker.
We propose a planar dipole antenna which has a fractal geometry which is inductively coupled with rectangular strips. The design modeling and simulation of the antenna was performed in ANSYS-HFSS v. 17.2. The fractal geometry is designed using the principle of Koch curve to achieve miniaturization. Also, the proposed Koch curve variant provided strong filling space and compact size having lower resonant frequency and low Q value [16] . Initially, a design consisting of symmetrically hexagonal fractal geometry with rectangular strips, as shown in Figure 3 (a) , was designed in a free space environment. Then, to achieve 954 MHz resonance, a rectangular strip was coupled with the designed fractal geometry. The resulting structure did not only significantly increase the overall electrical length of the structure but also increased the overall inductance of the antenna. Also, the antenna was designed using a low loss (tan δ = 0.0020) Rogers TMM10i substrate, the higher dielectric value ( r = 9.8) therefore helped achieve further miniaturized design at 954 MHz. Next, to design an implantable version of the proposed structure, a complex human heart tissue environment, using a cubical box in the simulation environment filled with a material having the dielectric properties of the heart tissue [36] , was modeled in HFSS and antenna model was inserted inside the heart tissue emulating model. The simulations results revealed a resonance shift in the antenna due to the lossy nature and high dielectric constant. Then, the antenna geometry was modified by altering the dimensions of the fractal geometry to achieve resonance at 954 MHz in heart tissue simulation environment. The layout of the final implantable fractal antenna is shown in Figure 3 (a). The prototype implantable antenna was manufactured by a standard fabrication process using a LPKF ProtoMat S63 milling machine. A photograph of the prototype antenna is shown in Figure 4 (a) and (d).
The measurements of the |S 11 | (in dB) and far-field performance were performed in an anechoic chamber using a well calibrated E5071C, Agilent Vector Network Analyzer. It can be observed in Figure 5 (a) that the proposed implantable antenna has good matching characteristics and also, good agreement is found between the simulation and measured results. It can be also be seen in Figure 5 (b) that the proposed antenna has a dumbbell-shaped radiation characteristics. The measured gain was 0.64 dBi at 954 MHz, however, a small variation in the simulated and measured results is because of the fabrication imperfections.
B. RECTIFIER AND MATCHING CIRCUIT
In order to achieve a full rectenna system, the input impedance of the rectifier must be matched to the antenna's impedance using a matching circuit. First, a modifiedGreinacher rectifier circuit was designed separately in Advanced Design System (ADS) circuit simulator. As shown in Figure 3 (b), this rectifier circuit was then matched to the dipole antenna using two identical inductors L f and L r , both of 12 nH inductance. The value of matching elements were determined via a series of experiments following the fabrication of the rectifier circuit.
Next, in order to achieve a small form factor, the rectifier and matching circuits were both integrated on the same layer of the planar dipole antenna. Additional pads, labeled as A, B, C, D, E, and F, were incorporated on the same plane and are shown in dark black in Figure 3(a) . The feed position of the antenna is at point P while the dipole arm connected to point R is the reference plane. Details of the components is provided in the caption of Figure 3 A simple experiment was performed to measure the performance of the proposed rectenna. A separately fabricated rectifier circuit was connected to a receiver horn antenna (HRN0118) and the harvested DC output voltage was measured while the RF power was transmitted from an identical horn antenna, kept at 20 cm distance. The measured output voltage (DC) and the efficiency of the realized rectifier circuit as a function of the input power, measured at 954 MHz, is shown in Figure 6 .
C. CHARGING ELEMENT, PACING CIRCUIT, AND LOAD
As observed from the schematic in Figure 3(b) , a 4µF charging capacitor has been used as a storage element to maximize the harvested voltage. In order to demonstrate the effectiveness of the proposed method for leadless pacing applications, a suitable pacing profile was generated using a PIC microprocessor, PIC12F18240. Considering the rest- ing heart rate of a sheep, 70-80 bpm [37] , the microprocessor was programmed to deliver three separate pacing profiles, i.e., at 110 bpm, 120 bmp and also at 130 bpm. The pacing circuit was separately fabricated and shown in Figure 4 (b). The output port(s) of the microprocessor were connected to Pads 1 and 2, which were eventually connected to Pin(s) 1 and 2, as shown in Figs. 4(c) and (e), to deliver the pacing.
The final demonstration of the leadless pacemaker was performed in vivo, it was hence important to understand the impedance characteristics of the heart muscle of the targeted subject -an ovine model. For this purpose, a separate in vivo experiment was performed, the schematic and picture of experiment are shown in Figure 7 (a) and (b), respectively. Details of the impedance measurement procedure is as follows:
Promptly following the euthanasia of an ovine model, the impedance measurement of the heart tissue was performed to fully characterize the pacing profile and match impedance with the pacemakers leads. The setup included two gold contact pins [38] , separated by 8 mm, inserted into the myocardium and connected to a signal generator while having a 100 resistor connected in series to the heart muscle, as shown in Figure 7 (b). A 5 V square wave was transmitted into the tissue at multiple frequencies from 0 to 10 KHz. Each measurement was repeated three times to better quantify the heart tissue impedance. Furthermore, the data was recorded on a two port oscilloscope for the comparison of the transmitted signal into the heart and returning signal from the heart. The data was then post processed in MATLAB to determine the overall impedance of the heart tissue, which involved a Fast Fourier Transformation of the recorded data. The analysis of the impedance characteristics revealed fundamental and higher order modes, referring to the real and imaginary components of the impedance. The average resistance and capacitance values were found to be approximately 665 and 59 nF, respectively.
In a separately designed experiment, this impedance value was used as a load while we fully characterized the pacing profile generated by the proposed microprocessor-based pacing circuit. To obtain the first (110 bpm), second (120 bpm), and third (130 bpm) pacing profile, the microprocessor was programmed to generate 18, 20 and 22 pulses. Each 1 ms pulse of 1.8 V magnitude was created after 496 ms delay and was separated from the next set of pulses with a 10 s delay. 
IV. DESIGN AND DEVELOPMENT OF WEARABLE TRANSMIT ARRAY ANTENNA
Following the laboratory validation of the rectenna design, a wearable transmit 1 × 2 array, as shown in Figure 8 , was also designed in HFSS v. 17.2. Two flared conducting strips having lengths λ g (guided wavelength) were inserted in the radiating plane of the design to increase the electrical length of the antenna and to achieve 954 MHz resonance. Whereas, semi-oval shaped truncations were incorporated in the ground plane of the design to achieve a directional beam for efficient RF energy transmission in ovine model. Additionally, a design symmetry in the flared conducting strips was adopted in the design to achieve a symmetrical radiation pattern in the E-plane and a good impedance matching characteristics. The 1 × 2 array was designed on RT/Duroid 6010 having a thickness of 0.254 mm to enable a conformable design for the wearable applications in order to achieve RF pacing. Moreover, the planar geometry of the transmitter antenna array was selected to substantially reduce power transfer efficiency, inductance and quality factor (Q) [15] . It was observed in the design process of the 1 × 2 transmit array that flared widths W 1 , W 2 , W 3 , and W 4 were responsible for the bandwidth. Whereas, the lengths L 1 and L 2 controlled the resonance frequency of the transmit array. Since the receiving antenna of the rectenna was designed and tested at 954 MHz, the transmit array was therefore optimized by varying its length to achieve the same resonance. After the design optimization in the simulation software, transmit array was fabricated for measurement purposes and a photograph of the fabricated prototype with detailed dimensions is shown in Figure 8 . Figure 9 depicts the |S 11 | and measured plane radiation pattern of the transmit antenna array at 954 MHz. It can be seen from Figure 9 (a) that the array has good impedance matching characteristics. Furthermore, the measured E-and H-plane radiation patterns are shown in Figure 9 (b) and the measured gain was 7 dBi. Overall, a good agreement was observed between the simulated and measured results.
V. IN VIVO PROCEDURE AND PACING EXPERIMENT
To test the full functionality and performance of the proposed rectenna-based leadless pacemaker and the wearable transmit-antenna, an in vivo experiment was performed using an 8 years old Dorset breed ovine model. This study was approved by the Institutional Animal Care & Use Committee (IACUC) under the protocol number A15028 and was performed at North Dakota State University, ND, USA.
A complete layout of the experiment setup is shown in Figure 10 . Following the anesthetic procedure, using IV Ketamine and Valium, the subject animal was intubated and maintained under anesthesia using 0-5% Isoflurane. During the experiment, the safety of the animal was ensured by its continuous vital monitoring such as heart rate, blood pressure, O 2 saturation, and CO 2 measurement. Following the general anesthesia, the animal was positioned in right lateral recumbency for easier access to the heart. To gain access to the heart, a thoracotomy was performed by an experienced surgeon and the heart was exposed. The prototype rectenna-based leadless pacemaker was then implanted at the apex of the left ventricle by inserting its two pins into VOLUME 7, 2019 FIGURE 10. A complete layout of the in vivo experiment setup used to test the proposed rectenna-based leadless pacemaker and the wearable antenna to demonstrate leadless pacing.
FIGURE 11.
A picture taken during the demonstration of successful leadless pacing experiment. The fabricated transmit-antenna array is positioned on the thorax and directed towards the heart of the ovine model, while the proposed rectenna-based leadless pacemaker is implanted (The RF signal generator and amplifier are not shown here. The animal's body is intentionally hidden behind the shaded region).
the myocardium and secured in place by suturing it to the myocardium using the two designated holes in its enclosure. The performance of the implant was evident from the live ECG but, for additional monitoring, instrumentation wires were also used to monitor the harvested output voltage. These wires, connected to the output of the rectenna, were navigated via the medial aspect of the thoracotomy. Next, following the successful implantation of the implant, the chest was sealed and the wearable 1×2 transmit antenna array was positioned on the chest to deliver the RF energy into the body. To ensure adequate insulation, the prototype transmit-antenna was insulated using a conformal coating and also a 1 cm thick foam was used as a cushion between the antenna and the animal's body, as shown in Figure 11 . The transmit RF power was of 21 dBm magnitude and comprised of a continuous sinusoid signal, which was created using an Agilent Signal Generator and had a power amplifier connected in series, as depicted in Figure 10 .
VI. RESULTS
To determine the efficacy of the implanted antenna and transmit array for providing cardiac rhythms, a six lead ElectroCardiogram (ECG) machine was attached to the ovine model. The transmit array antenna was conformed on the outer surface of the dorset model by placing a 1 cm thick foam in between to transmit the RF energy to rectenna for providing sufficient power for pacing. The purpose of the foam was to mitigate Electromagnetic Interference (EMI) and coupling because of the lossy sheep surface ( r = 53.4, σ = 1.055 S/m, and mass density = 1040 kg/m 3 [22] ). The placement of the transmit antenna array and distance from the implanted rectenna, i.e, 11 cm resulted in a far-field region, as for lossy muscle the far-field region ≥ 2D 2 /λ g ≥= 0.07 cm, where λ g = λ/ √ r . Additionally, to ensure that the transmitted RF power is within the safe level, as recommended by IEEE [25] , average SAR was calculated using;
where σ is the conductivity of the complex dorset's heart muscle in S/m, i.e. 1.055 S/m, E is the electric field strength of the transmitted antenna, and M d is the mass density of the heart tissue. The value of electric field strength in V/m, from the power density, was calculated by modifying the formulas given in [39] for the lossy tissue. The power density P d at a point of R (distance in meters) from the transmitting antenna is [39] ,
where P t , G t , and G r is the transmitted power (21 dBm), gain of the 1 × 2 transmit array (7 dBi), and gain of the receiver antenna (0.64 dBi), respectively. The electric field intensity E was estimated using,
In eq (3), η tissue is the intrinsic impedance of sheep's heart tissue and was calculated using, where µ o and µ r are the constant (4π×10 −7 H/m, and relative permeability of the heart tissue, i.e., 1. o is a constant value (8.85 × 10 −12 ) and tissue = 53.4 is the relative permittivity of the heart tissue.
To calculate the average SAR value, eq. (2) to eq. 4 were used to first determine the electric field strength, E. Then, eq. (4) was used to compute the average SAR value which was found to be 0.29 W/kg. Thus, the developed RF pacing system has average SAR value under the recommended limit [25] .
After the validation of the SAR limit, surface ECG readings were assessed during post anesthesia and experimental pacing. It can be observed in Figure 12 that the ECG of the post anesthesia ('Not Pacing' region) clearly manifested a P wave for atrial contraction, QRS peaks for ventricular depolarization, and T wave for ventricular re-polarization. The ECG recordings revealed a 120 BPM heart rate and mean arterial blood pressure (MAP) of 32 mmHg having a normal sinus rhythm, as depicted in Figure 12 . Moreover, a wide complex-paced rhythm was observed in the post anesthesia, whereas epicardium stimulations generated a narrow complex-paced rhythm in the pre-anesthesia, as shown in 'Not Pacing' region of Figure 12 .
While the leadless pacing was also demonstrated at 110 bmp and 130 bmp, only results of 120 bmp are presented here. As evident from the in vivo ECG results shown in Figure 12 , the instantaneous heart beat increased from 92 to 120 bmp when the RF source was turned 'ON'. This is computed by measuring the R-R interval i.e. the time between each QRS complex.
VII. DISCUSSION
Our system has some limitations, which are briefly summarized below. A fully practical pacing system will have the ability to sense the issues with a sick heart and will therefore provide pacing as and when needed; however, this is not true for our system which only provides non-demand pacing. The main focus of this work was on the wireless power delivery, however in future, sensing and communication ability will be added in the existing system. A summary of the previous work with a quantitative comparison of the proposed work with the state-of-the-art work is presented in Table 1 .
The proposed method of RF-powered leadless pacing via a wearable transmit-antenna may not be practically realizable in the daily life of a patient. The future version of this method may consider a recharging battery in the electrode, which will be charged while the patient is wearing the transmitting system.
While the work presented in this paper is novel, it is not ready for any clinical study and it will require extensive resources and further work for completion. This is true for many medical devices, the realization of which is both lengthy and costly. In addition, there are strict regulations regarding any medical device, especially for the proposed device, which comprises of a wirelessly powered implant and also a wearable part for transmitting the wireless energy into the body. In the US alone, there are three federal agencies, the Federal Communications Commission (FCC), the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), each with their own regulations and requirements, which had to be met before a device can be commercialized.
To address the FCC's compliance questions, the proposed device has to be compatible with other uses of the frequency spectrum. The selection of 954 MHz frequency, in this work, was only for demonstration purpose and is not an open frequency band. To advance the work further, an appropriate frequency band has to be selected in the future. Also, to obtain FDA's compliance, success rate of the proposed device and results from clinical trials have to be presented. This will only be possible followed by results from acute, subchronic, and chronic studies in animals. Additionally, this work successfully demonstrated leadless pacing using RF energy. However, continuous powering for the device with no on-board battery may not be best choice for pacemaker as it is not possible to use wearable RF transmitter in certain scenarios such as in-flight operation and during shower etc. The developed prototypes in this work can be used to charge a re-chargeable pacemaker battery which would further mitigate the risk of battery replacement using risky clinical procedures. We envision to seek further funding and establish a collaboration with a medical device company with common interest in this technology. Only the collaboration between academia and industry can yearn this proposed method towards ultimate perfect fruition.
VIII. CONCLUSION
While there are still many questions left unanswered about the practicality of the proposed RF-powered leadless pacing method for any future clinical studies in humans, we have demonstrated, in this research, that a wearable RF-powered leadless pacing is achievable. In this work, a miniature rectenna-based pacemaker, implanted at the left ventricle, successfully paced the heart of an ovine model while it was receiving its power wirelessly from the prototype wearable transmit-antenna array positioned outside the body. As an alternative to the conventional pacing method, which requires leads and battery to operate, this proposed method is promising and has the potential to transform the way pacing is delivered. With no leads and batteries involved, this proposed method is potentially much safer as it does not face the infection risks caused by the leads or longevity issues due to the battery. However, more work is needed to improve the overall design of the implant pacemaker, so that it can be delivered percutaneously via a minimally invasive approach. Moreover, a long term acute animal study would be essential to determine the future of this method. He was the Head of the Department of Electrical Engineering Department, Riphah International University, Lahore Campus, from 2015 to 2016. He is currently Researcher (Post-Doctorate Fellowship) with the University of Padova. He has authored or co-authored more than 50 peer-reviewed journal and conference papers. His current research interests include advanced techniques and technologies for antenna design for medical applications, phased array for radar systems, reconfigurable antennas for advance applications, UWB-MIMO antennas, and novel material-based antennas. VOLUME 7, 2019 
